Eley Financial Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
36,200
+948
| +3% | +$43.9K | 0.64% | 43 |
|
|
2025
Q1 | $2.1M | Buy |
35,252
+721
| +2% | +$42.9K | 0.84% | 36 |
|
|
2024
Q4 | $1.95M | Buy |
34,531
+1,910
| +6% | +$108K | 0.76% | 39 |
|
|
2024
Q3 | $1.69M | Sell |
32,621
-5,208
| -14% | -$269K | 0.68% | 41 |
|
|
2024
Q2 | $1.57M | Sell |
37,829
-1,241
| -3% | -$51.5K | 0.67% | 43 |
|
|
2024
Q1 | $2.12M | Buy |
39,070
+1,639
| +4% | +$88.9K | 0.91% | 36 |
|
|
2023
Q4 | $1.92M | Buy |
37,431
+554
| +2% | +$28.4K | 0.9% | 35 |
|
|
2023
Q3 | $2.14M | Buy |
36,877
+112
| +0.3% | +$6.51K | 1.09% | 28 |
|
|
2023
Q2 | $2.35M | Buy |
36,765
+415
| +1% | +$26.5K | 1.15% | 30 |
|
|
2023
Q1 | $2.52M | Buy |
36,350
+405
| +1% | +$28.1K | 1.3% | 27 |
|
|
2022
Q4 | $2.59M | Buy |
+35,945
| New | +$2.59M | 1.39% | 24 |
|